US EditionHow shoddy science is fueling a charge to restrict abortion pill access
- The Secretary of Health and Human Services, Robert F. Kennedy Jr., has directed the FDA to conduct a safety evaluation of mifepristone following concerns raised by a recently released unvetted report.
- The report, which was not published in a medical journal nor subjected to peer review, asserts that the incidence of serious complications from mifepristone is 22-fold greater than FDA estimates.
- Researchers and public health experts criticized the report as flawed junk science that exaggerates risks, relying on a broad definition of serious adverse events including routine side effects.
- The report analyzed 865,727 insurance claims yet failed to disclose its database, while critics say many abortions are not insurance-covered and call the study ideologically driven.
- Kennedy's review signals potential policy changes on mifepristone that may go through the White House, while anti-abortion groups continue tactics aiming to limit pill access.
Insights by Ground AI
Does this summary seem wrong?
3 Articles
3 Articles
All
Left
2
Center
Right
How shoddy science is fueling a charge to restrict abortion pill access – Mnnofa
Health and Human Services Secretary Robert F. Kennedy Jr. has tasked the Food and Drug Administration with conducting a safety review of mifepristone, a pill used in most U.S. abortions. Kennedy said this week that the review was warranted due to an “alarming” new report on serious adverse events released last month. “Clearly it indicates that, at very least, the label should be changed,” he told Sen. Josh Hawley, R-Mo., at a Senate budget heari…
Coverage Details
Total News Sources3
Leaning Left2Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
